Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2010

View Archived Issues

Medvir discovers novel selective cathepsin K inhibitors

Boehringer Ingelheim claims new inhibitors of microsomal prostaglandin E synthase 1

Italian scientists claim new agents with antimalarial activity

NeuroSearch discloses new potassium channel modulators

Gilead discloses clinical data on HCV NS3 protease inhibitor GS-9256

Characterization of filibuvir resistance in HCV patients when coadministered with PEG-INF/RBV

Dual PI3K-alpha/mTOR inhibitors discovered by Pfizer

Preclinical and phase I data presented on antimicrobial pleuromutilin BC-3781

Cheminpharma presents preclinical data on new MEK 1 inhibitor

Pfizer describes new oxazolidinone antibacterial

Hospira enters definitive merger agreement to acquire Javelin

EMA recommends Cell Therapeutics submit revised PIP for pixantrone

Swedish Orphan Biovitrum's Kiobrina improves preterm infant growth speed in phase II trial

Novel photosensitizer porphyrins discovered at CeramOptec

Silence Therapeutics and AstraZeneca extend siRNA delivery collaboration

FDA approves Stemedica's IND to evaluate stem cells in ischemic stroke patients

Dutogliptin reduces HbA1c in phase III trial in type 2 diabetes

Alexion reaches enrollment goals in Solaris trials in atypical hemolytic uremic syndrome

EMA's COMP notifies CytRX of positive opinion on bafetinib in CML

NeoPharm starts enrollment in phase II LE-DT trial in pancreatic cancer

Genentech and Seattle Genetics to renew antibody-drug conjugate collaboration

DBM receives NIH grant to continue developing anti-inflammatory phytochemicals

NanoBio and University of Michigan launch program for therapeutic intranasal HBV vaccine

FDA approves Zortress to prevent kidney transplant rejection in adults

Biotie maintains global rights to BTT-1023 for inflammatory diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...